Global Alpha Capital Management Ltd. Ani Pharmaceuticals Inc Transaction History

Global Alpha Capital Management Ltd.

$1.35 Billion
Q1 2024

A detailed history of Global Alpha Capital Management Ltd. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Global Alpha Capital Management Ltd. holds 390,750 shares of ANIP stock, worth $24.9 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

390,750

Previous 582,428 32.91%

Holding current value

$24.9 Million

Previous $32.1 Million 15.89%

% of portfolio

2.01%

Previous 2.59%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$54.2 - $69.69 $10.4 Million - $13.4 Million	-191,678 Reduced 32.91%	390,750 $27 Million
Q4 2023 Feb 09, 2024	BUY	$48.72 - $65.43 $2.77 Million - $3.72 Million	56,900 Added 10.83%	582,428 $32.1 Million
Q3 2023 Nov 13, 2023	BUY	$50.28 - $64.61 $3.63 Million - $4.66 Million	72,200 Added 15.93%	525,528 $30.5 Million
Q2 2023 Aug 10, 2023	SELL	$37.29 - $53.83 $359,214 - $518,544	-9,633 Reduced 2.08%	453,328 $24.4 Million
Q1 2023 May 09, 2023	BUY	$37.61 - $45.72 $505,102 - $614,019	13,430 Added 2.99%	462,961 $18.4 Million

Q4 2022 Feb 10, 2023	BUY	$31.9 - $41.95 $963,380 - $1.27 Million	30,200 Added 7.2%	449,531 $18.1 Million
Q3 2022 Nov 10, 2022	BUY	$29.83 - $38.01 $2.85 Million - $3.63 Million	95,600 Added 29.53%	419,331 $13.5 Million
Q2 2022 Aug 05, 2022	SELL	$23.09 - $33.46 $611,885 - $886,690	-26,500 Reduced 7.57%	323,731 $9.61 Million
Q1 2022 May 12, 2022	BUY	$26.91 - $47.15 $1.76 Million - $3.08 Million	65,400 Added 22.96%	350,231 $9.85 Million
Q4 2021 Feb 10, 2022	BUY	$32.97 - $56.85 $7.27 Million - $12.5 Million	220,399 Added 342.06%	284,831 $13.1 Million
Q3 2021 Nov 12, 2021	BUY	$26.48 - $35.99 $1.71 Million - $2.32 Million	64,432 New	64,432 $2.12 Million
Q4 2020 Feb 10, 2021	SELL	$23.69 - $31.47 $6.13 Million - $8.15 Million	-258,946 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$26.38 - $33.1 $429,994 - $539,530	-16,300 Reduced 5.92%	258,946 $7.31 Million
Q2 2020 Aug 13, 2020	BUY	$29.93 - $50.1 $1.72 Million - $2.88 Million	57,500 Added 26.41%	275,246 $8.9 Million
Q1 2020 May 13, 2020	BUY	$30.35 - $67.14 $1.46 Million - $3.22 Million	48,000 Added 28.28%	217,746 $8.87 Million
Q4 2019 Feb 12, 2020	BUY	$55.65 - $79.83 $1.26 Million - $1.81 Million	22,700 Added 15.44%	169,746 $10.5 Million
Q3 2019 Nov 13, 2019	BUY	$64.7 - $85.39 $297,620 - $392,794	4,600 Added 3.23%	147,046 $10.7 Million
Q2 2019 Aug 07, 2019	BUY	$67.77 - $82.2 $3.11 Million - $3.78 Million	45,935 Added 47.6%	142,446 $11.7 Million
Q1 2019 May 08, 2019	BUY	$45.83 - $70.54 $4.42 Million - $6.81 Million	96,511 New	96,511 $6.81 Million

Others Institutions Holding ANIP

# of Institutions

206

Shares Held

14M

Call Options Held

26.7K

Put Options Held

237K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.11B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Alpha Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Global Alpha Capital Management Ltd. with notifications on news.

Account

Global Alpha Capital Management Ltd. Ani Pharmaceuticals Inc Transaction History